Fitzgerald Ita, Crowley Erin K, Ní Dhubhlaing Ciara, O'Dwyer Sarah, Sahm Laura J
Pharmacy Department, St Patrick's Mental Health Services, Dublin, Ireland; and Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland.
Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland.
BJPsych Open. 2024 Aug 1;10(5):e136. doi: 10.1192/bjo.2024.725.
Antipsychotic-induced weight gain (AIWG) is a substantial contributor to high obesity rates in psychiatry. Limited management guidance exists to inform clinical practice, and individuals with experience of managing AIWG have had no or minimal input into its development. A lack of empirical research outlining patient values and preferences for management also exists. Recommendations addressing weight management in psychiatry may be distinctly susceptible to ideology and sociocultural values regarding intervention appropriateness and expectations of self-management, reinforcing the need for co-produced management guidance. This study is the first to ask: how do individuals conceptualise preferred AIWG management and how can this be realised in practice?
Qualitative descriptive methodology informed study design. A total of 17 participants took part in semi-structured interviews. Data analysis was undertaken using reflexive thematic analysis.
Participants reported that clinicians largely overestimated AIWG manageability using dietary and lifestyle changes. They also reported difficulties accessing alternative management interventions, including a change in antipsychotic and/or pharmacological adjuncts. Participants reported current management guidance is oversimplified, lacks the specificity and scope required, and endorses a 'one-size-fits-all' management approach to an extensively heterogenous side-effect. Participants expressed a preference for collaborative AIWG management and guidance that prioritises early intervention using the range of evidence-based management interventions, tailored according to AIWG risk, participant ability and participant preference.
Integration of this research into guideline development will help ensure recommendations are relevant and applicable, and that individual preferences are represented.
抗精神病药物所致体重增加(AIWG)是导致精神病学领域肥胖率居高不下的一个重要因素。目前针对临床实践的管理指导有限,且有AIWG管理经验的个体在其制定过程中未参与或参与极少。此外,也缺乏概述患者对管理的价值观和偏好的实证研究。关于精神病学体重管理的建议可能极易受到关于干预适宜性和自我管理期望的意识形态和社会文化价值观的影响,这进一步凸显了共同制定管理指导的必要性。本研究首次提出:个体如何构想首选的AIWG管理方式,以及如何在实践中实现这一点?
定性描述方法为研究设计提供了指导。共有17名参与者参加了半结构化访谈。采用反思性主题分析法进行数据分析。
参与者报告称,临床医生在很大程度上高估了通过饮食和生活方式改变来管理AIWG的可行性。他们还报告了在获得替代管理干预措施方面存在困难,包括更换抗精神病药物和/或使用药物辅助治疗。参与者表示,当前的管理指导过于简单,缺乏所需的特异性和范围,并且支持对广泛异质性的副作用采用“一刀切”的管理方法。参与者表示倾向于采用协作式AIWG管理和指导,优先使用一系列基于证据的管理干预措施进行早期干预,并根据AIWG风险、参与者能力和参与者偏好进行调整。
将本研究纳入指南制定将有助于确保建议具有相关性和适用性,并体现个体偏好。